<html>
<head>PUBMED IDs for SEMA3E</head>
<body bgcolor='#C5F0F2'><h1>SEMA3E</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16024618/'>Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.</a> July 19  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/21710492/'>ERK2 is essential for the growth of human epithelioid malignant mesotheliomas.</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/25985275/'>Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome.</a> August 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26086095/'>Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins.</a> October 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27572291/'>Enhanced expression of semaphorin 3E is involved in the gastric cancer development.</a> April 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27666723/'>Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.</a> September 27  2016<br></body></html>
